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Abstract. 
 
It has been proposed that the plasma mem-
brane of many cell types contains cholesterol-sphin-
golipid–rich microdomains. Here, we analyze the role 
of these microdomains in promoting oligomerization
of the bacterial pore-forming toxin aerolysin. Aeroly-
sin binds to cells, via glycosyl phosphatidylinositol-
anchored receptors, as a hydrophilic soluble protein 
that must polymerize into an amphipathic ring-like 
complex to form a pore. We ﬁrst show that oligomeriza-
 
tion can occur at 
 
.
 
10
 
5
 
-fold lower toxin concentration at 
the surface of living cells than in solution. Our observa-
tions indicate that it is not merely the number of recep-
tors on the target cell that is important for toxin sensi-
tivity, but their ability to associate transiently with 
detergent resistant microdomains. Oligomerization ap-
pears to be promoted by the fact that the toxin bound 
to its glycosyl phosphatidylinositol-anchored receptors, 
can be recruited into these microdomains, which act as 
concentration devices.
Key words: aerolysin • cholesterol • microdomains • 
glycosyl phosphatidylinositol-anchored protein • oligo-
merization 
 
M
 
ANY
 
 pathogenic bacteria produce pore-forming
toxins as important virulence factors to kill the
host cell or to perforate internal cell membranes
during bacterial invasion. Similarly, certain cells from the
immune system release the membrane attack complex or
perforin to perforate the plasma membrane of cells that
need to be killed. The modes of action of many pore-form-
ing toxins, of perforin, and of the ninth component of com-
plement are very similar. These proteins are initially solu-
ble and can diffuse towards their target cells to which they
bind via specific receptors. The proteins then undergo oli-
gomerization into ring-like amphipathic complexes that
are able to insert into membranes and form pores. Al-
though oligomerization is the key step in the channel for-
mation process of all these proteins (for review see Le-
sieur et al., 1997), it is still poorly understood. Here, we
have studied oligomerization of the pore-forming toxin
aerolysin at the surface of mammalian cells. This toxin
constitutes an attractive model to study pore formation in
biological membranes, since its soluble structure has been
solved and its in vitro mode of action extensively studied
(for review see Rossjohn et al., 1998).
Aerolysin is secreted by the human pathogen 
 
Aeromo-
nas hydrophila
 
, a member of the 
 
Vibrionaceae
 
 family. The
bacterium leads to a variety of infections ranging from
gastroenteritis to deep wound infection and septicemia.
Strong evidence implicates aerolysin as an important viru-
lence factor produced by the bacterium (Donta and Had-
dow, 1978; Daily et al., 1981; Kaper et al., 1981; Janda et al.,
1984). The toxin is secreted as an inactive soluble precur-
sor, proaerolysin (van der Goot et al., 1993a), that diffuses
towards the target cell where it binds to specific receptors.
A variety of receptors on different cell types have been
identified recently (Gruber et al., 1994; Cowell et al., 1997;
Nelson et al., 1997; Abrami et al., 1998b; Diep et al., 1998).
These receptors all have the common property of being at-
tached to the plasma membrane via a glycosyl phosphati-
dylinositol (GPI)
 
1
 
 anchor. Once bound to the cell surface,
the protoxin is activated by proteolytic removal of a
COOH-terminal peptide. This can be achieved by cell sur-
face furin (Abrami et al., 1998a), by digestive enzymes, or
by proteases produced by the bacterium (Howard and
Buckley, 1985). Aerolysin then oligomerizes into a hep-
tameric ring (Wilmsen et al., 1992; Moniatte et al., 1996).
This complex is amphipathic and is the membrane inser-
tion competent form (van der Goot et al., 1993b), which
penetrates into the membrane of the target cell to form a
channel. Therefore, as opposed to the barrel stave model
 
Address correspondence to Gisou van der Goot, Département de Bio-
chimie, Sciences II, 30 Quai Ernest-Ansermet, 1211 Geneva 4, Swit-
zerland. Tel.: (41) 022 702-6032. Fax: (41) 022 702-6414. E-mail: Gisou.
vandergoot@biochem.unige.ch
 
1. 
 
Abbreviations used in this paper:
 
 
 
b
 
-MCD, 
 
b
 
-methyl cyclodextrin; BHK,
baby hamster kidney; DIGs, detergent insoluble glycosphingolipid com-
plexes; GMEM, Glasgow minimal essential medium; GPI, glycosyl phos-
phatidylinositol; IM, incubation medium; PNS, postnuclear supernatant.  
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for channel formation, oligomerization precedes mem-
brane insertion. Channel formation leads to loss of small
molecules and ions triggering in dose-dependent manner
signaling cascades (Krause et al., 1998) and selective vac-
uolation of the endoplasmic reticulum (Abrami et al.,
1998b).
As mentioned above, proaerolysin receptors are GPI-
anchored proteins. These proteins, which are not trans-
membrane, but are anchored to the membrane via a lipid
moiety (Kinoshita et al., 1997), have attracted much atten-
tion lately, not only because of their role in signaling
events (Jones and Varela-Nieto, 1998), but also due to
their possible role in apical targeting in polarized epithe-
lial cells and their association with cholesterol glycosphin-
golipid-rich microdomains, also called lipid rafts (for re-
view see Parton and Simons, 1995; Edidin, 1997; Harder
and Simons, 1997; Simons and Ikonen, 1997; Brown, 1998;
Hooper, 1998; Brown and London, 1998; Jacobson and
Dietrich, 1999). It was the identification of lipid fractions
that were insoluble in nonionic detergents, such as Triton
X-100 at 4
 
8
 
C, that led to the proposal that these domains
form lipid microdomains within the plasma membrane
(see above reviews). However the actual existence of lipid
rafts in living cells has been a matter of debate (Sheets
et al., 1997; Friedrichson and Kurzchalia, 1998; Harder et al.,
1998; Kenworthy and Edidin, 1998; Varma and Mayor,
1998), and the issue has not yet been definitively solved
(for review see Jacobson and Dietrich, 1999).
Previously, we have shown that receptor-bound pro-
aerolysin is highly enriched in detergent insoluble com-
plexes (Abrami et al., 1998b). The aim of the present work
was to address the importance of the distribution of aeroly-
sin receptors at the plasma membrane for the oligomeriza-
tion process. Aerolysin provides an ideal model system for
these studies because the aerolysin heptamer is SDS resis-
tant and can, therefore, readily be visualized by SDS-
PAGE. In addition, cholesterol is not absolutely essential
for aerolysin binding and channel formation (van der
Goot et al., 1993b), thereby allowing manipulation of cel-
lular cholesterol to perturb the structure of microdomains.
Here, we first show that the aerolysin heptamer, in addi-
tion to proaerolysin, is present in the detergent in soluble
glycosphingolipid complexes (DIGs). Our data show that
disruption of the microdomains prevents toxin clustering
at the cell surface and dramatically inhibits oligomeriza-
tion. Based on these data, we propose that cholesterol-rich
microdomains act as specialized concentration devices on
the plasma membrane. Finally, evidence is provided that
processing of proaerolysin into aerolysin and oligomeriza-
tion are events that occur in topologically distinct areas of
the plasma membrane, highlighting the dynamic behavior
of GPI-anchored proteins at the cell surface.
 
Materials and Methods
 
Cells and Materials
 
Monolayers of baby hamster kidney (BHK) cells were grown and main-
tained as described (Gruenberg and Howell, 1989) in Glasgow minimal
essential medium (GMEM; Sigma Chemical Co.) supplemented with 5%
FCS, 2 mM 
 
L
 
-glutamine under standard tissue culture conditions. Triton
X-100 Ultra Pure was purchased from Pierce Chemical Co., BSA from
Biomol, and saponin, 
 
b
 
-methyl cyclodextrin (
 
b
 
-MCD), compactin, tryp-
 
sin, and trypsin/chymotrypsin inhibitor from Sigma Chemical Co. Anti-
bodies against the human transferrin receptor and proaerolysin were gifts
from I. Throwbridge (The Salk Institute for Biological Studies, San Diego,
CA) and J.T. Buckley (University of Victoria, British Columbia, Canada),
respectively. mAbs against caveolin-1 were purchased from Transduction
Laboratories.
 
Treatment of Cells with Cholesterol-affecting Drugs
 
BHK cells were grown, as described, for 16 h. Before the addition of the
toxin, the cells were washed three times with PBS containing 1 mM CaCl
 
2
 
,
1 mM MgCl
 
2
 
,
 
 
 
and 1 
 
m
 
g/ml of trypsin/chymotrypsin inhibitor (PBS
 
2
 
1
 
), and
treated with either 0.4% saponin in PBS
 
2
 
1 
 
for 1 h at 4
 
8
 
C or with 10 mM
 
b
 
-MCD for 1 h at 37
 
8
 
C in incubation medium (IM) containing GMEM
buffered with Hepes, pH 7.4, and 1 
 
m
 
g/ml of trypsin/chymotrypsin inhibitor.
 
Proaerolysin Purification, Iodination, and Activation
 
Proaerolysin was purified as described previously (Buckley, 1990). Con-
centrations were determined by measuring the OD at 280 nm, considering
that a 1 mg/ml sample has an OD of 2.5 (van der Goot et al., 1994a).
Proaerolysin was labeled with 
 
125
 
I using iodogen reagent (Pierce Chemical
Co.) according to the manufacturer’s recommendations. The radio-
labeled toxin was separated from the free iodine by gel filtration on a
PD10-G25 column (Pharmacia Biotech, Inc.) equilibrated with 150 mM
NaCl, 20 mM Hepes, pH 7.4. We consistently obtained a specific activity
of 
 
z
 
2.10
 
6
 
 cpm/
 
m
 
g of proaerolysin. Radiolabeled proaerolysin ran as a sin-
gle band on an SDS gel.
To activate proaerolysin into aerolysin in vitro, the protoxin was
treated with trypsin (1:20; mol:mol ratio) for 10 min at room temperature.
The reaction was stopped by addition of a 10-fold excess of trypsin/chy-
motrypsin inhibitor.
 
Proaerolysin Binding and Oligomerization on
BHK Cells
 
Confluent monolayers of BHK cells were washed three times for 5 min
with ice-cold PBS
 
2
 
1
 
. Cells were then incubated at 4
 
8
 
C with 
 
125
 
I-proaero-
lysin in IM. Cells were then washed three times for 10 min with PBS
 
2
 
1
 
 at
4
 
8
 
C and further incubated for various times at 37
 
8
 
C. Cells were then
rinsed three times with PBS
 
2
 
1
 
 at 4
 
8
 
C, scraped from the dish, and collected
by centrifugation at 1,500 rpm for 5 min. A Triton X-100 insoluble fraction
was prepared as described below or a postnuclear supernatant (PNS) was
prepared as follows. Cells were gently homogenized in 250 mM sucrose,
3 mM imidazole, pH 7.4, by passage through a 22G injection needle. The
PNS was obtained by centrifugation (2,500 rpm) and analyzed for the
presence of proaerolysin and aerolysin by SDS-PAGE, followed by auto-
radiography.
 
Triton X-100 Insolubility and Preparation of DIGs
 
The detergent extraction was performed as described previously (Brown
and Rose, 1992; Fra et al., 1994; Abrami et al., 1998b). BHK cells were
treated with 
 
125
 
I-proaerolysin and harvested as described above, and re-
suspended in 0.5 ml of cold buffer containing 25 mM Tris-HCl, 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100, as well as Complete, a cocktail of
protease inhibitors (Boehringer Mannheim Corp.). Membranes were sol-
ubilized by rotary shaking at 4
 
8
 
C for 30 min. The detergent insoluble frac-
tions were obtained either by high-speed centrifugation (30 min, 4
 
8
 
C, at
55,000 rpm in a TLS55 Beckman rotor) or purified on a sucrose gradient
as follows. The solubilized cell lysate sample was adjusted to 41% sucrose
(in 10 mM Tris-HCl, pH 7.4) in a SW40 Beckman tube, overlaid with 8.5 ml
of 35% sucrose, topped up with 16% sucrose, and centrifuged for 18 h at
35,000 rpm at 4
 
8
 
C. The initial load (1 ml), as well as 12 fractions of 1 ml,
were collected. Each of the fractions were counted in a Packard auto-
 
g
 
scintillation spectrometer and/or precipitated with 6% trichloroacetic acid
in the presence of 375 
 
m
 
g of sodium deoxycholate as a carrier. Each frac-
tion was analyzed by SDS-PAGE, followed by autoradiography or West-
ern blot analysis.
 
Immunofluorescence
 
BHK cells were grown for 16 h on 12 
 
3
 
 12-mm glass coverslips in GMEM
medium complemented with 2.5% FCS. Cells were left untreated or
treated with saponin or 
 
b
 
-MCD, as described above. After three washes 
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with PBS
 
2
 
1
 
at 4
 
8
 
C, cells were incubated for 1 h at 4
 
8
 
C with 2 nM of
proaerolysin, then washed three times for 10 min with PBS
 
2
 
1
 
 comple-
mented with 0.5% BSA at 4
 
8
 
C, further incubated for 1 h at 4
 
8
 
C with mAbs
against proaerolysin (1:40; Abrami et al., 1998b), and then washed briefly
at 4
 
8
 
C in PBS
 
2
 
1
 
–BSA. Further cross-linking with FITC secondary anti-
bodies (1:50) was performed at 4
 
8
 
C for 1 h. After washing, the cells were
fixed first in 3% paraformaldehyde in PBS for 4 min at 8
 
8
 
C and then in
methanol for 5 min at 
 
2
 
20
 
8
 
C. Cells were visualized using a Zeiss Axiophot
fluorescence microscope equipped with a cooled CCD camera (Princeton
Instruments), controlled by a Power Macintosh. The IPLab Spectrum 3.1
software (Signal Analytics Corp.) was used for data acquisition.
 
Analytical Techniques and Proaerolysin Overlays
 
Potassium efflux measurements were performed by flame photometry us-
ing a Philips PYE UNICAM SP9 atomic absorption spectrophotometer as
described previously (Abrami et al., 1998a,b). Protein concentrations of
cellular fractions were determined with bicinchoninic acid (BCA; Pierce
Chemical Co.). Proaerolysin overlays, to detect proaerolysin receptors,
were performed as described previously (Abrami et al., 1998b). In brief,
membrane fractions were run on a 12.5% SDS gel (Laemmli, 1970). The
gel was incubated in 50 mM Tris-HCl, pH 7.4, and 20% glycerol for 15
min. Proteins were then blotted onto a nitrocellulose membrane for 15 h
at 100 mA in the cold using a BioRad wet transfer chamber with a transfer
buffer containing 10 mM NaHCO
 
3
 
 and 3 mM Na
 
2
 
CO
 
3
 
, pH 9.8. The nitro-
cellulose membrane was incubated in a binding buffer containing 50 mM
NaH
 
2
 
PO
 
4
 
, pH 7.5, and 0.3% Tween-20 for 20 min followed by a 2 h incu-
bation in the presence of 1.4 nM 
 
125
 
I-proaerolysin diluted in the same
buffer. The membrane was then washed six times for 5 min with toxin-free
binding buffer. Binding of proaerolysin was revealed by autoradiography
using BioMax films (Kodak). When performing Western blot analysis,
HRP-labeled secondary antibodies were revealed using enhanced chemi-
luminescence (Pierce Chemical Co.). Total cholesterol contents of cells
were determined using a colorimetric method following the instructions of
the manufacturer (Boehringer Mannheim Corp.).
 
Results
 
Oligomerization Is Dramatically Enhanced at the 
Surface of Target Cells
 
Aerolysin is able to form heptamers in solution in the ab-
sence of membranes (van der Goot et al., 1994b; Parker
et al., 1996; Rossjohn et al., 1998). However, this process
is not very efficient. As can be seen in Fig. 1 a, at a toxin
concentration of 4 
 
m
 
M, 
 
,
 
50% of the toxin had oligomer-
ized, even after 1 h incubation at 37
 
8
 
C. In marked con-
trast, oligomerization occurred efficiently on the surface
of target cells, such as BHK cells. When BHK cells were
incubated with a 10
 
4
 
-fold lower concentration of toxin
(0.4 nM), 25 min at 37
 
8
 
C was sufficient to observe almost
complete oligomerization (Fig. 1 a, in vivo). Oligomer-
ization and channel formation occurred at even lower
doses, such as 1 pM of aerolysin, as witnessed by measur-
ing the intracellular potassium concentration 1 h after
toxin addition (Fig. 1 b). Thus, oligomerization at the cell
surface can occur at bulk toxin concentrations 10
 
5
 
–10
 
6
 
-
fold lower than those required to detect oligomerization
in solution.
 
All Forms of the Toxin Are Enriched in Triton X-100 
Insoluble Complexes
 
Previous observations indicated that the toxin was associ-
ated with DIGs of the plasma membrane (Abrami et al.,
1998b). Here we investigated whether all forms of the
toxin, i.e., not only proaerolysin, but also mature aerolysin
and the heptamer, were enriched in DIGs. 
 
125
 
I-Proaero-
lysin was bound to cells at 4
 
8
 
C. Cells were then incubated
either with proaerolysin at 4
 
8
 
C or with aerolysin (obtained
by in vitro activation with trypsin) at 4
 
8
 
C followed by 10
min at 37
 
8
 
C to allow heptamerization (Abrami et al.,
1998a,b). Cells were subsequently solubilized in Triton
X-100 and DIGs were purified on a sucrose flotation gra-
dient as described in Materials and Methods. As shown in
Fig. 2, not only proaerolysin was highly enriched in the
low-density DIGs in agreement with our previous obser-
vations (Abrami et al., 1998b), but also mature aerolysin
and the heptamer.
We next quantified the fraction of the total toxin that
was associated with detergent insoluble domains as a func-
tion of the incubation time at 37
 
8
 
C. As previously shown
(Abrami et al., 1998a), 45% of the toxin initially bound to
the cells at 4
 
8
 
C was released into the medium upon incuba-
tion at 37
 
8
 
C, the remaining 65%, however, was stably
bound to the cells (Fig. 3 a). We then investigated whether
the distribution of the cell-bound toxin would change with
time. In these experiments, toxin-treated cells were incu-
bated for different times at 37
 
8
 
C, then solubilized in cold
Triton X-100 and submitted to a high-speed centrifuga-
tion. The amounts of toxin in the detergent insoluble pel-
let and in the solubilized fraction were determined. As can
be seen in Fig. 3 b, the amount of toxin associated with de-
tergent-resistant membranes increased with time, consis-
tent with the notion that the toxin was being recruited into
these microdomains, presumably because of oligomeriza-
tion.
Figure 1. Oligomerization of
aerolysin is more efficient in
vivo than in vitro. a, To fol-
low oligomerization in vitro,
proaerolysin at a concentra-
tion of 4 mM was activated
with trypsin as described in
Materials and Methods. The
sample was then incubated at
378C for 1 h and analyzed by
SDS-PAGE, followed by
Coomassie staining. The
aerolysin heptamer (333 kD)
is SDS resistant and can be
visualized at the top of the
gel. For the in vivo oligo-
merization experiment, 125I-
proaerolysin at a concentra-
tion of 0.4 nM was activated
in solution with trypsin and
added to BHK cells at 48C for
1 h. Cells were then washed
and incubated for 25 min at
378C. A PNS was prepared
and analyzed by SDS-PAGE,
followed by autoradiography.
b, To measure potassium ef-
flux from BHK cells at differ-
ent toxin concentrations,
cells were incubated with aerolysin for 1 h at 378C and the cellu-
lar potassium contents were determined by flame photometry.
Experiments were done in triplicate and the SDs were calculated. 
The Journal of Cell Biology, Volume 147, 1999 178
 
Effects of Cholesterol Interacting Drugs on the 
Distribution of Proaerolysin
 
Since all forms of aerolysin were found in DIGs, we inves-
tigated whether disruption of these microdomains had any
influence on the protoxin cleavage and oligomerization
processes. The integrity of microdomains has been shown
to depend on cholesterol (for review see Brown, 1998;
Harder et al., 1998; Rietveld and Simons, 1998). More-
over, cholesterol has been shown to be implicated in the
detergent insolubility of GPI-anchored proteins (Cerneus
et al., 1993; Hannan et al., 1993; Hanada et al., 1995;
Scheiffele et al., 1997; Harder et al., 1998; Schroeder et al.,
1998). We therefore analyzed the effect of cholesterol-
affecting drugs on the association of proaerolysin with de-
tergent insoluble membrane domains. It is important to
note, that, in contrast to what is observed with pore-form-
ing toxins, such as streptolysin O and other members of
the thiol-activated toxin family, no requirement for choles-
terol has ever been observed for channel formation by
aerolysin in artificial phospholipid membranes, suggesting
that cholesterol does not play any crucial structural role in
aerolysin channel formation and can, therefore, be manip-
ulated in the present experiments.
Two drugs were tested: 
 
b
 
-MCD and saponin. 
 
b
 
-MCD is
an effective extracellular cholesterol acceptor that can ex-
tract cholesterol from membranes (Kilsdonk et al., 1995;
Neufeld et al., 1996). Saponin, in contrast, binds to choles-
terol and sequesters it away from other interactions, but
does not extract it from the membrane (Elias et al., 1978;
Schroeder et al., 1998). Under the experimental conditions
used, 50 
 
6 
 
2% (
 
n
 
 5 
 
4) of total cellular cholesterol was re-
moved by 
 
b
 
-MCD, whereas the cholesterol content of sa-
ponin-treated cells was the same as that of control cells, as
expected. After drug treatment, cells were incubated with
 
125
 
I-proaerolysin for 1 h at 4
 
8
 
C. Neither drug prevented
 
Figure 2.
 
Proaerolysin, aerolysin, and heptameric aerolysin are
enriched in Triton X-100 insoluble microdomains.
 
 125
 
I-proaero-
lysin or trypsin-activated 
 
125
 
I-aerolysin (0.4 nM) were bound to
cells at 4
 
8
 
C for 1 h. Cells were then washed and directly solubi-
lized in Triton X-100 (proaerolysin-treated cells) or first incu-
bated for 10 min at 37
 
8
 
C (aerolysin-treated cells) to allow oligo-
merization, and then solubilized in Triton X-100. DIGs were
purified on sucrose density gradients as described in Materials
and Methods. The initial 1-ml Triton X-100 lysat was loaded at
the bottom of the tube corresponding to fraction 13. The amount
of radioactivity (a) associated with each fraction of the gradient
Figure 3. The amount of toxin associated
with detergent resistant membranes increases
with time. BHK monolayers were incu-
bated  with  125I-proaerolysin (0.4 nM) for 1 h
at 48C, then extensively washed and further
incubated for different times at 378C. a, The
amount of radioactivity associated with the
cells and released into the medium was deter-
mined and expressed as a percent of the total.
b, Cells were solubilized in Triton X-100 and
submitted to a high-speed centrifugation. The
total radioactivity in the detergent insoluble
pellets and the detergent soluble supernatants
were determined and expressed as a percent
of the total. Error bars represent the mean of
four experiments.
 
was counted and the protein concentration of each fraction was
determined (b). The enrichment profile of toxin (c) was analyzed
by SDS-PAGE, followed by autoradiography by loading the
same amount of protein (20 
 
m
 
g) in each lane.
 
 
 
All forms of the
toxin were enriched in the low-density fractions. 
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binding of the toxin to the cells (see Figs. 6–8). Toxin-
treated cells were then solubilized in cold Triton X-100,
submitted to a high-speed centrifugation, and the amounts
of toxin in the detergent insoluble pellet and in the solubi-
 
lized fraction were determined. As shown in Fig. 4 a, 
 
b
 
-MCD
led to a mild redistribution of proaerolysin to the deter-
gent soluble fraction. However, after saponin treatment,
 
.
 
80% of cell bound proaerolysin was associated with the
detergent soluble fraction. Similar observations were made
when purifying DIGs by sucrose density centrifugation
from proaerolysin-treated cells. The distribution of pro-
aerolysin along the gradient after 
 
b
 
-MCD treatment (re-
sults not shown) was similar to that observed for control
cells (Fig. 2 a). Therefore, the toxin was still highly en-
riched in DIGs after 
 
b
 
-MCD treatment, but this was no
longer the case after saponin treatment (Fig. 4 b). How-
ever, saponin did not disrupt all DIGs since the caveolar
marker caveolin-1 was still highly enriched in the light
density detergent insoluble fractions of the gradient, as
also observed for control cells (Fig. 4 c) and cells treated
with 
 
b
 
-MCD (results not shown).
Previously, we have shown that receptor bound pro-
aerolysin can be clustered using antitoxin antibodies, and
that clustering leads to a characteristic punctate distri-
bution by immunofluorescence (Abrami et al., 1998b).
Within these clusters, the toxin was found to fully colocal-
ize with antibody cross-linked alkaline phosphatase and
partially with caveolin-1 (Abrami et al., 1998b). Similar
antibody-induced clustering has been observed for a
variety of GPI-anchored proteins (for review see Brown
and London, 1998). We have investigated whether treat-
ments with 
 
b
 
-MCD or saponin would affect this antibody-
induced clustering capacity. The staining pattern found on
 
b
 
-MCD–treated cells (Fig. 5 b) was similar to that ob-
served on control cells. In contrast, a diffuse staining was
observed when cells were treated with saponin (Fig. 5 c)
indicating that, under these conditions, even a sandwich of
primary and secondary antibodies, before cell fixation,
could not induce clustering of proaerolysin bound to its re-
ceptor.
The above experiments indicate that cholesterol re-
moval with 
 
b
 
-MCD did not alter the ability of proaero-
lysin to associate with microdomains, but that cholesterol
clustering with saponin led to a redistribution of the recep-
tor-bound toxin over the entire plasma membrane. These
experiments also suggest that 
 
b
 
-MCD and saponin affect
different pools of cholesterol within the plasma mem-
brane.
 
b
 
-MCD Leads to an Acceleration of
Protoxin Processing
 
Despite the lack of effect of 
 
b-MCD on steady state
proaerolysin distribution, we analyzed the effect of the
drug on the cleavage and oligomerization processes. In-
terestingly, we found that b-MCD treatment led to a
dramatic acceleration of the proteolytic processing of
proaerolysin into aerolysin (Fig. 6 a). In contrast, there
was no effect on the oligomerization kinetics, as can be
seen when treating cells with aerolysin that had been acti-
vated in vitro to bypass the cell surface activation step
(Abrami et al., 1998a; Fig. 6 b). The same observation was
made when b-MCD was present throughout the experi-
ment (including incubation with the toxin at 378C) in addi-
tion to the cholesterol synthesis inhibitor compactin. Our
interpretation of the effects of b-MCD is that the drug fa-
Figure 4. Effect of cholesterol-affecting drugs on the distribution
of proaerolysin. BHK monolayers were treated or not with b-MCD
(10 mM in IM at 378C for 1 h) or saponin (0.4% in PBS21 at 48C
for 1 h). Cells were then incubated with 125I-proaerolysin (0.4
nM) for 1 h at 48C and solubilized in Triton X-100. a, To separate
the detergent insoluble complexes from the solubilized material,
the samples were centrifuged at high speed. The total radioactiv-
ity in the pellets and the supernatants were determined and ex-
pressed as a percent of the total. b, DIGs were prepared by su-
crose density gradient. The initial 1-ml Triton X-100 lysat was
loaded at the bottom of the tube corresponding to fraction 13.
The amount of toxin in each fraction was counted. The protein
content of each fraction was determined by BCA protein assay.
More than 85% of the total protein content was found in frac-
tions 11 to 13 (results not shown). The enrichment factors were
calculated as follows: (counts in fraction x 4 protein content of
fraction x) 4 (total counts on gradient 4 total protein on gradi-
ent). The results are the mean of at least two experiments (con-
trol, n 5 9; saponin, n 5 5; b-MCD, n 5 2). c, DIGs obtained
from saponin-treated or control cells, as in b, were analyzed by
SDS-PAGE, followed by Western blotting to detect the presence
of the caveolar marker, caveolin-1. The same amounts of protein
(20 mg) were loaded in each lane to show enrichment.The Journal of Cell Biology, Volume 147, 1999 180
vored the interaction between the enzyme and protoxin
because the drug affected regions of the plasma mem-
brane that contain the proaerolysin-processing enzyme,
but does not significantly affect the microdomains en-
riched in GPI-anchored proteins (Figs. 4 b and 5 b). Previ-
ously, we have shown that processing of proaerolysin at
the cell surface is primarily performed by the endopro-
tease furin (Seidah and Chretien, 1997; Molloy et al., 1999)
in both CHO (Abrami et al., 1998a) and BHK cells (our
unpublished results). We could not detect any in vitro pro-
cessing of proaerolysin bound to DIGs, suggesting that fu-
rin is not present to any significant extent in microdomains
(results not shown).
Saponin Treatment Leads to the Inhibition of
Aerolysin Oligomerization
As shown in Fig. 4 a, saponin led to a dramatic redistribu-
tion of proaerolysin to the detergent soluble fraction of
Triton X-100–treated cells. This treatment, however, did
not lead to solubilization of the plasma membrane since
the total phospholipid content of saponin-treated cells was
the same as that of control cells, as measured using the
Fiske-Subbarow phosphore determination method (re-
sults not shown). As mentioned above, the total choles-
terol content was similar to that of control cells. Also, the
plasma membrane distribution of the transferrin receptor
was not affected by the treatment (results not shown). Fi-
nally, toxin receptors were not solubilized by this treat-
ment since binding of aerolysin was not affected, and the
same amount of receptors could be detected in control and
saponin-treated cells using our previously established
toxin overlay assay (Fig. 7 a). This overlay assay led to the
identification of various GPI-anchored proaerolysin bind-
ing proteins, including a 130- and a 80-kD protein, the
80-kD protein being apparently the most abundant recep-
tor (Abrami et al., 1998b).
The redistribution of proaerolysin to the detergent solu-
ble fractions upon saponin treatment was paralleled by a
redistribution of the proaerolysin receptors (Fig. 7 b), indi-
cating that solubilization of the toxin is not due to an effect
of the drug on the toxin-receptor interaction. Previously, it
has been shown that saponin treatment led to the Triton
X-100 solubilization of other GPI-anchored proteins (Cer-
neus et al., 1993; Hanada et al., 1993, 1995).
Figure 5. Antibody cross-
linking of receptor bound
proaerolysin at the cell sur-
face. BHK cells were treated
or not with b-MCD (10 mM
in IM at 378C for 1 h) or sa-
ponin (0.4% at 48C for 1 h),
then incubated consecutively
at 48C with proaerolysin (2
nM) for 1 h, with anti-
proaerolysin mAbs for 1 h,
and finally with FITC-labeled
secondary antibodies for 1 h.
Cells were then fixed first in
3% paraformaldehyde in
PBS for 4 min at 88C and then in methanol for 5 min at 2208C. The punctate pattern observed in b-MCD cells (b) was similar to that ob-
served in control cells (a), but could not be found in any of the saponin-treated cells (c). Similar patterns were observed when fixing
cells with paraformaldehyde (5 min at 48C, followed by 20 min at room temperature) only, even after treatment with 0.2% or 0.4% sa-
ponin for 30 min at 48C. The staining observed in the nuclear region in saponin-treated cells is due to background staining of the anti-
body and can also be seen when cells have not been treated with the toxin (results not shown). This staining is absent in control and
b-MCD–treated cells because the cells are not permeabilized during antibody treatment. Bar, 10.5 mm.
Figure 6. b-MCD does not affect oligomerization, but dramati-
cally accelerates protoxin processing. BHK monolayers were
treated with b-MCD (10 mM in IM at 378C for 1 h), then incu-
bated with either 125I-proaerolysin (a) or trypsin-activated 125I-
aerolysin (b; 0.4 nM) for 1 h at 48C and subsequently incubated at
378C for various times (indicated in minutes on the figure). PNSs
were prepared and analyzed by SDS-PAGE, followed by autora-
diography (20 mg of protein were loaded per lane). After b-MCD
treatment, conversion of proaerolysin into aerolysin was dramat-
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We next tested the effects of saponin both on cleavage
of proaerolysin by furin and on heptamerization kinetics.
Cells were treated with saponin at 48C, then incubated in
the presence of proaerolysin at 48C, and further incubated
for various times at 378C. As shown in Fig. 8 a, the kinetics
of cleavage were not affected by saponin, in contrast to
what we observed with b-MCD (Fig. 6 a). This observa-
tion indicates that overall cell surface dynamics were not
significantly affected by saponin-treatment. In contrast,
oligomerization was dramatically inhibited, as can clearly
be seen when treating cells with aerolysin activated in
vitro with trypsin (Fig. 8 b). This was not due to some ef-
fect of saponin on the toxin itself, since saponin had no
effect on oligomerization kinetics in vitro (results not
shown). Similar observations were made on other cell
types, such as CHO cells or the polarized human intesti-
nal cell line, CaCoII (results not shown). Saponin pre-
vented clustering of cell surface-bound toxin and dramati-
cally inhibited the oligomerization process.
Since the toxin was no longer found in microdomains
and showed uniform cell surface labeling, yet remained
bound to its receptor, it is likely that saponin caused the
receptors and their bound toxin molecules to become
evenly distributed in the plane of the plasma membrane by
preventing any clustering. The absence of clustering due to
saponin would reduce the probability of encounter of
toxin monomers and thereby the efficiency of oligomeriza-
tion. If so, one might expect to, at least to some extent,
counteract the action of saponin by increasing the amount
of cell-bound toxin, hence the probability of toxin mono-
mer–monomer interactions. As can be seen in Fig. 8 c, this
is indeed the case. When higher toxin concentrations were
added to the saponin-treated cells, oligomerization did oc-
cur. The efficiency of the process, however, remained
much lower than on control cells, further strengthening
the importance of toxin concentration within microdo-
mains on the oligomerization process.
Discussion
The present work illustrates the surface dynamics of pro-
Figure 7. Effects of saponin
treatment on aerolysin bind-
ing and receptor distribu-
tion. a, BHK monolayers
were left untreated or treated
with saponin (0.4% at 48C for
1 h) and then incubated with
125I-proaerolysin (0.4 nM) for
1 h at 48C. PNSs were pre-
pared and analyzed by SDS-
PAGE, followed by autora-
diography, to detect bound
toxin; or by toxin overlay, fol-
lowed by autoradiography, to
detect the proaerolysin re-
ceptors (20 mg of protein
were loaded per lane). All
bands detected by toxin over-
lay are GPI-anchored pro-
teins and can no longer be
detected when cells have
been treated with the phos-
phatidyl inositol-specific phospholipase C (Abrami et al., 1998b).
b, BHK monolayers were left untreated or treated with saponin,
as in a. Cells were scrapped, pelleted, and resuspended in 1% Tri-
ton X-100 at 48C. Membranes were solubilized by rotary shaking
at 48C for 30 min. The detergent insoluble fractions were ob-
tained by high-speed centrifugation (30 min at 48C at 55,000
rpm). Detergent insoluble (I) and soluble (S) fractions were ana-
lyzed by SDS-PAGE, followed by autoradiography, to detect
bound toxin; or by toxin overlay, followed by autoradiography, to
detect the proaerolysin receptors. One tenth of each fraction was
loaded per lane (corresponding to z80 mg of the Triton X-100
soluble fraction) to analyze the recovery of the toxin and its re-
ceptors.
Figure 8. Saponin inhibits the kinetics of aerolysin oligomeriza-
tion. BHK monolayers were left untreated or treated with
saponin (0.4% at 48C for 1 h). Cells were then incubated with
125I-proaerolysin (0.4 nM; a) or in vitro trypsin-activated 125I-
aerolysin (0.4 nM; b) for 1 h at 48C, washed, and further incu-
bated for various times at 378C (indicated in minutes on the fig-
ure). PNSs were prepared and analyzed by SDS-PAGE, followed
by autoradiography (20 mg of protein were loaded per lane). Af-
ter prolonged incubation at 378C, a slight loss of cell-bound toxin
is observed in saponin-treated cells for reasons that remain to be
established. c, BHK monolayers were left untreated or treated
with saponin as in a, and then incubated for 1 h at 48C with differ-
ent concentrations of in vitro trypsin-activated 125I-aerolysin. At
all concentrations tested, binding of aerolysin to the cells was
specific. Cells were then washed and further incubated for 25 min
at 378C. PNSs were prepared and analyzed by SDS-PAGE, fol-
lowed by autoradiography.The Journal of Cell Biology, Volume 147, 1999 182
aerolysin upon binding to its GPI-anchored receptor on
target cells. Proaerolysin must first be proteolytically pro-
cessed to become active. The toxin then oligomerizes into
a heptameric ring, a step that precedes membrane inser-
tion and channel formation (van der Goot et al., 1993b).
Using two cholesterol-perturbing drugs, we could selec-
tively affect the kinetics of processing or of oligomeriza-
tion, suggesting that the two events occur in topologically
distinct areas of the plasma membrane. Processing ap-
peared to occur in the phosphoglyceride region, whereas
oligomerization was most efficient in cholesterol-rich mi-
crodomains, which act as concentration devices at the cell
surface.
Proaerolysin Processing
Previously, we have shown that processing of proaerolysin
at the cell surface is primarily performed by the endopro-
tease furin (Abrami et al., 1998a). Since furin contains a
canonical Tyr-based and a dileucine-like internalization
signal in its cytoplasmic tail, it is thought to be internalized
via clathrin-coated pits (for review see Seidah and Chre-
tien, 1997; Molloy et al., 1999). Furin is therefore expected
to be in the phosphoglyceride region of the membrane and
not in cholesterol-rich microdomains. In agreement, we
could not detect any proaerolysin converting activity in
purified microdomains.
We found that b-MCD treatment of cells, which led to
the removal of z50% of total cholesterol, accelerated the
processing of proaerolysin, presumably by increasing the
lateral mobility of both furin and receptor-bound pro-
aerolysin. In contrast, the drug did not affect the ability of
the toxin to associate with detergent resistant micro-
domains. Our interpretation is that b-MCD extracted cho-
lesterol from a pool that is not involved in the association
of GPI-anchored proteins with microdomains. Cholesterol
is indeed not only found in raft-like microdomains, but
also in the fluid phosphoglyceride regions (Chong, 1994),
and has also been predicted to accumulate at the edge of
microdomains (Cruzeiro-Hansson et al., 1989; Gil et al.,
1998). In agreement with our observations, Ilangumaran
and Hoessli (1998) suggested that b-MCD only affects
cholesterol surrounding and outside of GPI-containing mi-
crodomains. However, effects of b-MCD on the distribu-
tion of GPI-anchored proteins have been observed also
(Friedrichson and Kurzchalia, 1998; Harder et al., 1998).
These differences in the observed effects of b-MCD might
be due to differences in cell lines and/or in culture condi-
tions.
Aerolysin Oligomerization
The next crucial step in the channel formation process of
aerolysin is oligomerization. Previously, we have shown
that in vitro, in the absence of membranes, at physiological
salt concentrations and temperature, heptamers can only
form when the toxin concentration is higher than 1 mM
(van der Goot et al., 1992). On target cells, however, oligo-
merization was found to occur even when adding a 105-
fold lower aerolysin concentration. Several factors might
contribute to this increased efficiency of oligomerization.
Binding of the toxin to its receptors directs it to its tar-
get cell. Moreover, since the estimated binding dissocia-
tion constant (Kd) is low (Abrami et al., 1998b), it can be
expected that binding also concentrates the toxin. Indeed,
as discussed first by Adam and Delbrück (1968) and later
by McLaughlin and Aderem (1995), membrane binding
reduces the dimensionality from three to two. Using the
Guggenheim model of a surface (McLaughlin and Ad-
erem, 1995), we calculated that toxin binding to its recep-
tor leads to an increase in concentration by a factor of
z1,500 (see Appendix). Although this estimate may be
approximate, it strongly suggests that binding cannot
solely account for increased efficiency of oligomerization
observed at the cell surface, as compared with in solution.
Additional factors are likely to contribute. Here, we show
that cholesterol-rich microdomains play an important role.
Due to the long and saturated acyl chains of the GPI-moi-
ety, GPI-anchored proteins have the capacity to associate
transiently with lipid rafts (Brown and London, 1998). We
found that on cells that had been treated with the choles-
terol-binding drug saponin, proaerolysin lost its capacity
to associate with microdomains (Fig. 4) and to cluster
upon cross-linking with antibodies (Fig. 5 c). Concomi-
tantly, saponin led to a dramatic inhibition of aerolysin oli-
gomerization, without altering toxin activation kinetics,
suggesting that the concentration threshold required for
heptamer formation could no longer be reached, even lo-
cally. Oligomerization could, however, be forced when
adding higher amounts of toxin to saponin-treated cells,
but remained far less efficient, as expected.
These results show that microdomains act as concentra-
tion platforms at the cell surface, due to their ability to re-
cruit GPI-anchored proteins, and that aerolysin has hi-
jacked this device to suit its own purpose. When the same
number of toxin receptors were dispersed at the plasma
membrane and prevented from clustering by saponin
treatment, oligomerization either did not occur at all or ki-
netics were dramatically inhibited, depending on the toxin
concentration. The corollary of these observations is that
having surface receptors that can cluster renders cells
more sensitive to low doses of toxin. Recently, it has been
proposed by Bray et al. (1998) that receptor clustering
could be a cellular mechanism to control the sensitivity of
a cell to a given ligand. Backed-up by a mathematical
model, they proposed that the sensitivity and response
range of chemotatic bacteria to attractants depend on the
clustering of the chemotatic receptors on the cell surface
(Bray et al., 1998). The present findings demonstrate ex-
perimentally that this proposal is correct for pore-forming
toxins, such as aerolysin.
We believe the importance of microdomains for effi-
cient oligomerization will extend to other pore-forming
proteins, both toxins and proteins, from the immune re-
sponse (Fivaz et al., 1999). Vibrio Cholera cytolysin has
been shown to require both cholesterol and sphingolipids
to form channels in vitro (Zitzer et al., 1999). Lysenin, a
pore-forming toxin for earthworms, has been shown to
bind to sphingomyelin (Lange et al., 1997; Yamaji et al.,
1998). Both these toxins, which require oligomerization
for channel formation, are likely to bind to cholesterol-
sphingolipid–rich microdomains on living cells. A major
class of pore-forming toxins is composed of the so-called
thiol-activated toxins, which include streptolysin O, lyste-
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of this family require cholesterol to form pores (Bhakdi
et al., 1996), even though cholesterol might not be the re-
ceptor, as initially thought (Jacobs et al., 1998). Choles-
terol binding to these toxins probably triggers a conforma-
tional change necessary for membrane insertion. We
would like to speculate that cholesterol, in addition, tar-
gets thiol-activated toxins to microdomains to increase in
local toxin concentration to promote oligomerization.
Clustering of thiol-activated toxins is probably even more
important than for aerolysin, since the pores contain an
average of 50 monomers (Lesieur et al., 1997). Similarly,
the pores formed by the ninth component of complement
contain z20 monomers (Peitsch and Tschopp, 1991).
In the present work, we describe the journey of pro-
aerolysin on the plasma membrane of the target cell and
how the toxin makes use of the peculiar properties of its
GPI-anchored receptors to optimize its toxic action. Im-
portantly, GPI-anchored proteins can be found both scat-
tered in the phosphoglyceride region of the plasma mem-
brane and clustered in the microdomains. Indeed, only
z35% of the GPI-anchored protein Thy-1 was found in
microdomains at steady state, as judged by a single particle
tracking analysis (Sheets et al., 1997). Once bound to its
receptor, proaerolysin must move about to encounter its
processing enzyme furin in the phosphoglyceride region of
the plasma membrane. This lateral movement is favored
by the lipid anchor of the receptor. It has indeed been
shown that GPI-anchored proteins have a higher lateral
mobility within a phospholipid bilayer than their trans-
membrane counterpart (Zhang et al., 1992). Subsequent
encounters between toxin subunits, required for the aero-
lysin oligomerization step, is favored by the capacity of the
GPI-anchored receptors to associate with cholesterol-rich
microdomains and to remain confined to them for several
seconds (Sheets et al., 1997). This clustering device en-
ables the toxin to concentrate locally and therefore to oli-
gomerize efficiently. Cholesterol-rich microdomains, thus,
appear to act as concentration platforms and offer sites of
assembly for the aerolysin heptamer. In addition, micro-
domains might provide an ideal location for membrane
insertion of the toxin. At the junctures between choles-
terol-sphingolipid–rich domains and fluid phase phospho-
glyceride domains, there are probably unfavorable ener-
getic effects (Brown, 1998) that locally weaken the lipid
bilayer and might favor membrane penetration. The route
followed by aerolysin at the cell surface nicely illustrates
the highly dynamic behavior of raft components and the
transitory nature of the interaction of GPI-anchored pro-
teins with cholesterol-rich microdomains. The present
work also provides functional evidence for the existence of
rafts at the surface of living cells.
Appendix
To estimate the factor by which proaerolysin becomes
concentrated when binding to the BHK cell surface, the
following calculation was made: 2.5 ml of 125I-proaerolysin
at a concentration of 0.4 nM was added to a 56.7-cm2 con-
fluent petri dish. We found routinely that z5% of 125I-
proaerolysin was bound at 378C, i.e., 10213 mol of toxin. In a
calculation similar to that described by McLaughlin and
Aderem (1995), we considered that the bound toxin was
located in a thin, but finite, region adjacent to the mem-
brane, of thickness d, where d is of molecular dimensions
(1 , d , 10 nm). This surface phase corresponds to the
Guggenheim model of a surface. Therefore, upon translo-
cation of 10213 mol of toxin to volume of d 5 10 nm 3 56.7
cm2, the concentration in the surface phase would be 1.3 mM,
leading to a concentration factor of z1,500, when com-
pared with the bulk toxin.
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